169 related articles for article (PubMed ID: 24185859)
21. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
Diabetes Res Clin Pract; 2017 Aug; 130():121-129. PubMed ID: 28602812
[TBL] [Abstract][Full Text] [Related]
22. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
23. Asymptomatic hypoglycaemia: identification and impact.
Gomis R; Esmatjes E
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S47-9. PubMed ID: 15551298
[TBL] [Abstract][Full Text] [Related]
24. How hypoglycaemia can affect the life of a person with diabetes.
Frier BM
Diabetes Metab Res Rev; 2008 Feb; 24(2):87-92. PubMed ID: 18088077
[TBL] [Abstract][Full Text] [Related]
25. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.
Frier BM
Nat Rev Endocrinol; 2014 Dec; 10(12):711-22. PubMed ID: 25287289
[TBL] [Abstract][Full Text] [Related]
26. Prevention and treatment of hypoglycaemia unawareness in type 1 diabetes mellitus.
Bolli GB
Acta Diabetol; 1998 Dec; 35(4):183-93. PubMed ID: 9934816
[TBL] [Abstract][Full Text] [Related]
27. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
[TBL] [Abstract][Full Text] [Related]
28. Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon.
Thieu VT; Mitchell BD; Varnado OJ; Frier BM
Diabetes Obes Metab; 2020 Apr; 22(4):469-479. PubMed ID: 31820562
[TBL] [Abstract][Full Text] [Related]
29. The role of structured education in the management of hypoglycaemia.
Iqbal A; Heller SR
Diabetologia; 2018 Apr; 61(4):751-760. PubMed ID: 28660491
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of hypoglycemia in patients with type 1 diabetes].
Radermecker RP; Jandrain B; Paquot N; Philips JC; Contessi E; Lavigne M; Rinaldi AM; Scheen AJ
Rev Med Liege; 2003 Jun; 58(6):361-8. PubMed ID: 12945232
[TBL] [Abstract][Full Text] [Related]
31. Insulin analogues and severe hypoglycaemia in type 1 diabetes.
Kristensen PL; Hansen LS; Jespersen MJ; Pedersen-Bjergaard U; Beck-Nielsen H; Christiansen JS; Nørgaard K; Perrild H; Parving HH; Thorsteinsson B; Tarnow L
Diabetes Res Clin Pract; 2012 Apr; 96(1):17-23. PubMed ID: 22136722
[TBL] [Abstract][Full Text] [Related]
32. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
[TBL] [Abstract][Full Text] [Related]
33. Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?
Heller SR; Amiel SA; Evans ML; Kong MF; Macdonald IA; Peacey SR
Diabetes Obes Metab; 2002 Mar; 4(2):106-12. PubMed ID: 11940107
[TBL] [Abstract][Full Text] [Related]
34. How has psycho-behavioural research advanced our understanding of hypoglycaemia in type 1 diabetes?
Hendrieckx C; Gonder-Frederick L; Heller SR; Snoek FJ; Speight J
Diabet Med; 2020 Mar; 37(3):409-417. PubMed ID: 31814151
[TBL] [Abstract][Full Text] [Related]
35. Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?
Rogers HA; de Zoysa N; Amiel SA
Diabet Med; 2012 Mar; 29(3):321-7. PubMed ID: 21913969
[TBL] [Abstract][Full Text] [Related]
36. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
Davis T; Salahi A; Welsh JB; Bailey TS
Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
[TBL] [Abstract][Full Text] [Related]
37. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
38. Self-reported non-severe hypoglycaemic events in Europe.
Östenson CG; Geelhoed-Duijvestijn P; Lahtela J; Weitgasser R; Markert Jensen M; Pedersen-Bjergaard U
Diabet Med; 2014 Jan; 31(1):92-101. PubMed ID: 23796113
[TBL] [Abstract][Full Text] [Related]
39. Hypoglycaemia unawareness.
Meijer E; Hoekstra JB; Erkelens DW
Presse Med; 1994 Apr; 23(13):623-7. PubMed ID: 8029194
[TBL] [Abstract][Full Text] [Related]
40. Insulin therapy and hypoglycaemia: the size of the problem.
Fanelli CG; Porcellati F; Pampanelli S; Bolli GB
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S32-42. PubMed ID: 15551297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
